v3.26.1
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Balance Sheet (Details) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Schedule of Previously Reported Condensed Consolidated and Combined Balance Sheet [Line Items]                
Preferred stock, value    
Common stock, value 774 746   13,169 11,733 8,709 8,689  
Additional paid-in capital 159,453,519 159,027,646   101,998,956 93,968,741 82,483,948 81,928,282  
Stock subscription receivable (2,919,674) (2,841,427)   (2,545,586) (2,476,160) (80,241) (80,241)  
Accumulated Deficit (164,803,207) (163,372,539)   (122,368,539) (110,290,958) (100,573,062) (122,487,488)  
Total Stockholders’ Equity (Deficit) $ (8,268,588) $ (7,185,574) $ (12,183,292) (22,902,000) (18,786,644) (18,160,646) (40,630,758) $ 3,412,459
As Reported [Member]                
Schedule of Previously Reported Condensed Consolidated and Combined Balance Sheet [Line Items]                
Preferred stock, value        
Common stock, value       13,169 11,733 8,709 8,689  
Additional paid-in capital       93,045,581 85,617,896 79,610,239 79,158,563  
Stock subscription receivable       (80,241) (80,241) (80,241) (80,241)  
Accumulated Deficit       (115,880,509) (104,336,032) (97,699,353) (119,717,769)  
Total Stockholders’ Equity (Deficit)       (22,902,000) (18,786,644) (18,160,646) (40,630,758) 3,412,459
Adjustments [Member]                
Schedule of Previously Reported Condensed Consolidated and Combined Balance Sheet [Line Items]                
Preferred stock, value        
Common stock, value        
Additional paid-in capital       8,953,375 8,350,845 2,873,709 2,769,719  
Stock subscription receivable       (2,465,345) (2,395,919)  
Accumulated Deficit       (6,488,030) (5,954,926) (2,873,709) (2,769,719)  
Total Stockholders’ Equity (Deficit)